Why this FTSE 100 growth stock could be a bargain

Bilaal Mohamed uncovers two blue-chip bargains from the FTSE 100 (INDEXFTSE:UKX).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shares in Ferguson (LSE: FERG) were up 3% in early trading this morning as the plumbing and heating giant delivered another good set of results, driven by favourable residential and commercial markets in the US, which account for the majority of the group’s revenues.

UK remains weak

The FTSE 100 giant, which changed its name from Wolseley in the summer, is the world’s largest specialist trade distributor of plumbing and heating products to professional contractors, principally operating in North America and the UK.

For the financial year to 31 July, Ferguson reported revenue in the ongoing businesses of £14.9bn, compared to the £12.1bn it delivered in 2016, with trading profit coming in 8.7%, ahead of last year at £1.03bn. In light of the strong performance, management announced a £500m share buyback programme, and hiked the full-year dividend by 10%.

Flies in the ointment

There were a couple of flies in the ointment however. Industrial markets, which account for 7% of US revenue, were weak in the first half though recovered well in the second. The heating market also remained pretty weak here in the UK.

But the fact remains that around 89% of the group’s trading profits are derived from US markets, where organic revenue growth has been strong. Here, the residential and commercial markets had a particularly good year, delivering growth of 9%-10% and 7%-8%, respectively. These end markets are easily the most important for the group, accounting for around 85% of total US revenue.

The shares are recovering from a slump during the summer, and investors would be best advised to stake their claim before the valuation gets too demanding. At 15.5 times forecast earnings for FY2018, I still see Ferguson as a rare blue-chip bargain, but for how long?

Open Access

Another blue-chip that looks undervalued at the moment is events and publishing giant Informa (LSE: INF). The FTSE 100 group provides products and services based on content, intelligence and connections to specialist communities worldwide. These include academic books and journals, data-driven intelligence publications and services, exhibitions, conferences and learning platforms.

Last week, management announced the acquisition of independent Open Access (OA) publisher Dove Medical Press for an undisclosed sum. The privately held company specializes in the publication of OA peer-reviewed journals across the broad spectrum of science, technology and especially medicine. It’s hoped the deal will improve Informa’s position and capability in the growing OA market.

Stable business

Over the years, Informa has demonstrated a solid reputation for consistent growth, and the acquisition of Dove Medical Press should help to add strength and capability to its existing OA portfolio, further increasing choice and flexibility for researchers across a widening range of subject areas.

I see the recent pull-back in the share price as a great opportunity for investors to buy into a relatively stable business at a very reasonable price. Informa trades on a relatively modest earnings multiple of just 14 for the current year to December.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Bilaal Mohamed has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Illustration of flames over a black background
Investing Articles

2 red-hot UK growth stocks to consider buying in April

These two growth stocks are performing well, but can they continue to deliver for investors through 2024 and beyond?

Read more »

Charticle

Is JD Sports Fashion one of the FTSE 100’s best value stocks? Here’s what the charts say!

The JD Sports Fashion share price remains a wild ride during the first quarter. Could it be one of the…

Read more »

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »